Key facts
- This page summarizes Michael Singer's Form 4 filing for Cartesian Therapeutics, Inc. (RNAC).
- 14 reported transactions and 8 derivative rows are listed below.
- Accepted by SEC: 10 Apr 2024, 21:47.
Michael Singer - 08 Apr 2024 Form 4 Insider Report for Cartesian Therapeutics, Inc. (RNAC)
- Reporting relationship
- Director
- Issuer ticker
- RNAC
- Reported as of
- 08 Apr 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 10 Apr 2024, 21:47:15 UTC
- Prior SEC filing
- 04 Jan 2024
- Next SEC filing
- 21 Nov 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Matthew Bartholomae, Attorney-in-Fact for Michael Singer
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Michael Singer filed Form 4 for Cartesian Therapeutics, Inc. (RNAC) on 10 Apr 2024.
Change
- Previous filing in this sequence was filed on 04 Jan 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RNAC
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +110,151
- Change %
- +1147%
- Price
- Shares after
- 119,754
- Date
- 08 Apr 2024
- Ownership
- Direct
- Footnotes
- F1, F2
RNAC
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +377,208
- Change %
- +5726%
- Price
- Shares after
- 383,796
- Date
- 08 Apr 2024
- Ownership
- by trust
- Footnotes
- F1, F2, F3
RNAC
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +55,746
- Change %
- +5729%
- Price
- Shares after
- 56,719
- Date
- 08 Apr 2024
- Ownership
- by trust
- Footnotes
- F1, F2, F4
RNAC
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +7,005
- Change %
- +5742%
- Price
- Shares after
- 7,127
- Date
- 08 Apr 2024
- Ownership
- by trust
- Footnotes
- F1, F2, F5
RNAC
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +14,535
- Change %
- +5745%
- Price
- Shares after
- 14,788
- Date
- 08 Apr 2024
- Ownership
- by spouse
- Footnotes
- F1, F2, F6
RNAC
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +94,568
- Change %
- +5728%
- Price
- Shares after
- 96,219
- Date
- 08 Apr 2024
- Ownership
- as custodian
- Footnotes
- F1, F2, F7
RNAC
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +94,568
- Change %
- +5728%
- Price
- Shares after
- 96,219
- Date
- 08 Apr 2024
- Ownership
- as custodian
- Footnotes
- F1, F2, F8
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
RNAC
transaction
Derivative
Series A Non-Voting Convertible Preferred Stock
Options Exercise
- Transaction value
- Shares
- -3,305
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 08 Apr 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 110,151
- Exercise price
- Footnotes
- F1, F2
RNAC
transaction
Derivative
Series A Non-Voting Convertible Preferred Stock
Options Exercise
- Transaction value
- Shares
- -11,316
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 08 Apr 2024
- Ownership
- by trust
- Underlying class
- Common Stock
- Underlying amount
- 377,208
- Exercise price
- Footnotes
- F1, F2, F3
RNAC
transaction
Derivative
Series A Non-Voting Convertible Preferred Stock
Options Exercise
- Transaction value
- Shares
- -1,672
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 08 Apr 2024
- Ownership
- by trust
- Underlying class
- Common Stock
- Underlying amount
- 55,746
- Exercise price
- Footnotes
- F1, F2, F4
RNAC
transaction
Derivative
Series A Non-Voting Convertible Preferred Stock
Options Exercise
- Transaction value
- Shares
- -210
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 08 Apr 2024
- Ownership
- by trust
- Underlying class
- Common Stock
- Underlying amount
- 7,005
- Exercise price
- Footnotes
- F1, F2, F5
RNAC
transaction
Derivative
Series A Non-Voting Convertible Preferred Stock
Options Exercise
- Transaction value
- Shares
- -436
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 08 Apr 2024
- Ownership
- by spouse
- Underlying class
- Common Stock
- Underlying amount
- 14,535
- Exercise price
- Footnotes
- F1, F2, F6
RNAC
transaction
Derivative
Series A Non-Voting Convertible Preferred Stock
Options Exercise
- Transaction value
- Shares
- -2,837
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 08 Apr 2024
- Ownership
- as custodian
- Underlying class
- Common Stock
- Underlying amount
- 94,568
- Exercise price
- Footnotes
- F1, F2, F7
RNAC
transaction
Derivative
Series A Non-Voting Convertible Preferred Stock
Options Exercise
- Transaction value
- Shares
- -2,837
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 08 Apr 2024
- Ownership
- as custodian
- Underlying class
- Common Stock
- Underlying amount
- 94,568
- Exercise price
- Footnotes
- F1, F2, F8
RNAC
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,600
- Date
- 08 Apr 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,600
- Exercise price
- $19.66
- Footnotes
- F2, F9
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 9 footnotes
Footnote F1
On March 27, 2024, the issuer held a special meeting of stockholders (the "Special Meeting"). At the Special Meeting, the stockholders of the issuer approved a 1-for-30 reverse stock split (the "Reverse Stock Split") of the issuer's common stock ("Common Stock") and the conversion of the issuer's Series A Non-Voting Convertible Preferred Stock ("Series A Preferred Stock") into shares of Common Stock. On April 8, 2024, the conversion of the majority of the shares of Series A Preferred Stock occurred automatically (the "Automatic Conversion"). The remaining shares of Series A Preferred Stock remain subject to certain beneficial ownership limitations described in the issuer's filings with the Securities and Exchange Commission. At the time of the Automatic Conversion, all of the reporting person's shares of Series A Preferred Stock converted into shares of Common Stock.
Footnote F2
On April 4, 2024, the issuer effected the Reverse Stock Split. The amount of securities reported on this Form 4 has been adjusted to reflect the Reverse Stock Split.
Footnote F3
Shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse is a trustee of this trust.
Footnote F4
Shares are held in a trust for which the reporting person is a beneficiary. The reporting person is a trustee of this trust.
Footnote F5
Shares are held in a trust for which the reporting person is a beneficiary. The reporting person's spouse is a trustee of this trust.
Footnote F6
Shares are held by the reporting person's spouse.
Footnote F7
The shares are held for LS, the child of the reporting person, through a custodial account established pursuant to the Uniform Transfer to Minors Act ("UTMA") for which the reporting person serves as custodian.
Footnote F8
The shares are held for SS, the child of the reporting person, through a custodial account established pursuant to the UTMA for which the reporting person serves as custodian.
Footnote F9
This award will vest in 36 equal monthly installments, so that it shall be fully vested on the third anniversary of the date of grant.